Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:45 PM
Ignite Modification Date:
2025-12-24 @ 10:45 PM
NCT ID:
NCT01851135
Eligibility Criteria:
Inclusion Criteria for Patients :
* NF1 diagnosis following National Institutes of Health criteria (1988)
* Age: 8-12 years for children, 18-59 years for adults
* Signed informed written consent (parent and patient for children, patient for adults)
* French speaking
* Resident in France
Inclusion Criteria for Healthy controls:
* Absence of NF1 diagnosis, learning disabilities, intellectual precocity
* Age: 8-12 years for children, 18-59 years for adults
* Signed informed written consent (parent and healthy control for children, healthy control for adults)
* French speaking
* Resident in France
Exclusion Criteria:
* Uncorrectable hearing of visual impairment
* History of psychiatric illness
* Neuropsychological investigation in the last 6 months
* Insufficient language usage
* Any other known history of central nervous system pathology or neuropathological complications of NF1
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
8 Years
Maximum Age:
59 Years
Study:
NCT01851135
Study Brief:
Protocol Section:
NCT01851135